Medline Inc. MDLN
Set alert
At close · Oct 30
After hours · Oct 30, 4:33 PM ET
- YTD
- -23.52%
- 1 year
- -21.66%
- Open
- 31.93
- Prev close
- 32.00
- Mkt cap
- 43.22B
- Vol
- 14.57M
- Avg vol
- 8.39M
- EPS
- 0.40
- P/E
- 80.30
- Div yield
- 0.00%
More statistics
- Low
- 31.37
- High
- 32.32
- Forward P/E
- 20.46
- Beta
- 0.00
- Short ratio
- 4.51
- Inst. own
- 112.01%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 34.52
- 200-d avg
- 39.70
- 1y target
- 44.31
5D chart
Signals (116)
| Name | Time | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 30, 3:50 PM | 2 days ago |
| SMA: Bullish | Oct 30, 3:40 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 3:15 PM | 2 days ago |
| SMA: Bearish | Oct 30, 2:55 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 2:05 PM | 2 days ago |
| SMA: Bullish | Oct 30, 1:55 PM | 2 days ago |
| SMA: Bullish | Oct 30, 1:50 PM | 2 days ago |
| SMA: Bearish | Oct 30, 1:20 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 1:15 PM | 2 days ago |
| SMA: Bearish | Oct 30, 1:05 PM | 2 days ago |
| SMA: Bullish | Oct 30, 12:55 PM | 2 days ago |
| SMA: Bearish | Oct 30, 12:50 PM | 2 days ago |
| SMA: Bullish | Oct 30, 12:25 PM | 2 days ago |
| SMA: Bearish | Oct 30, 12:20 PM | 2 days ago |
| SMA: Bullish | Oct 30, 12:10 PM | 2 days ago |
| SMA: Bullish | Oct 30, 12:10 PM | 2 days ago |
| SMA: Bearish | Oct 30, 12:00 PM | 2 days ago |
| SMA: Bullish | Oct 30, 11:40 AM | 2 days ago |
| SMA: Bullish | Oct 30, 11:35 AM | 2 days ago |
| SMA: Bearish | Oct 30, 11:05 AM | 2 days ago |
| MACD: Buy Signal | Oct 30, 10:40 AM | 2 days ago |
| SMA: Bullish | Oct 30, 10:30 AM | 2 days ago |
| SMA: Bearish | Oct 30, 9:45 AM | 2 days ago |
| SMA: Bearish | Oct 30, 9:45 AM | 2 days ago |
| SMA: Bullish | Oct 30, 9:40 AM | 2 days ago |
| SMA: Bullish | Oct 30, 9:40 AM | 2 days ago |
| SMA: Bearish | Oct 30, 9:35 AM | 2 days ago |
| SMA: Bearish | Oct 30, 9:35 AM | 2 days ago |
| MACD: Sell Signal | Oct 30, 9:35 AM | 2 days ago |
| SMA: Bullish | Oct 30, 9:30 AM | 2 days ago |
| SMA: Bullish | Oct 30, 9:30 AM | 2 days ago |
| MACD: Buy Signal | Oct 30, 9:30 AM | 2 days ago |
| MACD: Sell Signal | Oct 29, 4:00 PM | 3 days ago |
| SMA: Bearish | Oct 29, 3:50 PM | 3 days ago |
| SMA: Bearish | Oct 29, 3:45 PM | 3 days ago |
| SMA: Bullish | Oct 29, 3:30 PM | 3 days ago |
| SMA: Bullish | Oct 29, 3:15 PM | 3 days ago |
| SMA: Bearish | Oct 29, 2:55 PM | 3 days ago |
| SMA: Bearish | Oct 29, 2:55 PM | 3 days ago |
| SMA: Bullish | Oct 29, 2:35 PM | 3 days ago |
| SMA: Bullish | Oct 29, 2:10 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 1:55 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:40 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:25 PM | 3 days ago |
| SMA: Bearish | Oct 29, 11:40 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 11:30 AM | 3 days ago |
| RSI: Overbought | Oct 29, 10:50 AM | 3 days ago |
| SMA: Bullish | Oct 29, 10:10 AM | 3 days ago |
| SMA: Bearish | Oct 29, 10:05 AM | 3 days ago |
| RSI: Overbought | Oct 29, 9:55 AM | 3 days ago |
| SMA: Bullish | Oct 28, 3:55 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 3:30 PM | 4 days ago |
| SMA: Bullish | Oct 28, 3:25 PM | 4 days ago |
| RSI: Oversold | Oct 28, 3:05 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 2:50 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:45 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 2:40 PM | 4 days ago |
| SMA: Bullish | Oct 28, 2:30 PM | 4 days ago |
| RSI: Oversold | Oct 28, 2:20 PM | 4 days ago |
| SMA: Bearish | Oct 28, 1:50 PM | 4 days ago |
| SMA: Bearish | Oct 28, 12:55 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:50 PM | 4 days ago |
| SMA: Bearish | Oct 28, 12:45 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 12:30 PM | 4 days ago |
| SMA: Bearish | Oct 28, 12:20 PM | 4 days ago |
| SMA: Bullish | Oct 28, 11:00 AM | 4 days ago |
| SMA: Bullish | Oct 28, 11:00 AM | 4 days ago |
| SMA: Bearish | Oct 28, 10:45 AM | 4 days ago |
| SMA: Bullish | Oct 28, 10:10 AM | 4 days ago |
| SMA: Bearish | Oct 28, 9:55 AM | 4 days ago |
| RSI: Oversold | Oct 28, 9:55 AM | 4 days ago |
| SMA: Bullish | Oct 28, 9:50 AM | 4 days ago |
| SMA: Bearish | Oct 28, 9:45 AM | 4 days ago |
| MACD: Buy Signal | Oct 28, 9:45 AM | 4 days ago |
| SMA: Bullish | Oct 28, 9:40 AM | 4 days ago |
| RSI: Oversold | Oct 27, 2:55 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 2:40 PM | 5 days ago |
| SMA: Bearish | Oct 27, 2:25 PM | 5 days ago |
| SMA: Bullish | Oct 27, 2:20 PM | 5 days ago |
| SMA: Bearish | Oct 27, 2:15 PM | 5 days ago |
| SMA: Bullish | Oct 27, 2:10 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 2:10 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 1:50 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 1:45 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 1:30 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 1:15 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 1:10 PM | 5 days ago |
| SMA: Bearish | Oct 27, 12:05 PM | 5 days ago |
| SMA: Bullish | Oct 27, 12:00 PM | 5 days ago |
| SMA: Bearish | Oct 27, 11:45 AM | 5 days ago |
| SMA: Bullish | Oct 27, 11:35 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 11:20 AM | 5 days ago |
| SMA: Bearish | Oct 27, 11:05 AM | 5 days ago |
| SMA: Bullish | Oct 27, 11:00 AM | 5 days ago |
| SMA: Bearish | Oct 27, 10:50 AM | 5 days ago |
| SMA: Bullish | Oct 27, 10:40 AM | 5 days ago |
| RSI: Oversold | Oct 27, 10:15 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:45 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:45 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 9:45 AM | 5 days ago |
| SMA: Bullish | Oct 27, 9:35 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:30 AM | 5 days ago |
| SMA: Bullish | Oct 26, 3:15 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 3:00 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 2:55 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 2:50 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 2:30 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 2:25 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 2:10 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 1:25 PM | 6 days ago |
| SMA: Bullish | Oct 26, 1:15 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 12:50 PM | 6 days ago |
| SMA: Bearish | Oct 26, 12:30 PM | 6 days ago |
| SMA: Bearish | Oct 26, 12:25 PM | 6 days ago |
| SMA: Bullish | Oct 26, 11:05 AM | 6 days ago |
| SMA: Bearish | Oct 26, 10:20 AM | 6 days ago |
News
10 hours ago benzinga.com
Earnings Volatility Watch: 10 Stocks Are Set to Swing More Than 10% This Week
Ten stocks carry implied earnings moves above 10% next week, led by Moderna and AppLovin. Five are tech names hit in Friday's chip rout.
2 days ago globenewswire.com
MDLN Stock Market Alert: Medline Under Investigation for Potential Securities Fraud Over Product Quality Issues – Contact BFA Law if You Lost Money
NEW YORK, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its…
3 days ago prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN
NEW YORK, Oct. 29, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN). Such investors are advised to contact…
4 days ago globenewswire.com
$MDLN Stock Market Alert: Medline Investigated for Securities Fraud after Product Quality Issues Lead to 13% Stock Drop – Contact BFA Law if You Lost Money
NEW YORK, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its…
5 days ago globenewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN
NEW YORK, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Medline Inc. (“Medline” or the “Company”) (NASDAQ: MDLN). Such investors are advised to…
6 days ago globenewswire.com
$MDLN Stock Losses: BFA Law Reminds Medline Investors with Losses of the Ongoing Securities Fraud Investigation into Potential Product Quality Misrepresentations
NEW YORK, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its…
1 week ago globenewswire.com
MDLN Investigation News: Medline Investors are Notified of the Pending Securities Fraud Investigation – Contact BFA Law if You Lost Money
NEW YORK, Oct. 23, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its…
1 week ago prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN
NEW YORK, Oct. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN). Such investors are advised to contact…
-
1 week ago benzinga.com
Mizuho Maintains Outperform on Medline, Lowers Price Target to $45
Mizuho analyst Steven Valiquette maintains Medline (NASDAQ:MDLN) with a Outperform and lowers the price target from $48 to $45.
1 week ago globenewswire.com
MDLN Loss Notice: Medline Investors are Reminded of the Pending Securities Fraud Investigation – Contact BFA Law if You Lost Money
NEW YORK, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its…
1 week ago globenewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN
NEW YORK, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Medline Inc. (“Medline” or the “Company”) (NASDAQ: MDLN). Such investors are advised to…
1 week ago globenewswire.com
MDLN Investigation Reminder: Medline Investors that Lost Money after the 13% Stock Drop are Notified to Contact BFA Law
NEW YORK, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its…
2 weeks ago defenseworld.net
Medline $MDLN Stock Acquired by Banque Pictet & Cie SA
Banque Pictet and Cie SA boosted its position in shares of Medline (NASDAQ: MDLN) by 2.0% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned…
2 weeks ago globenewswire.com
MDLN Securities Announcement: Medline Investors with Losses may have Rights in an Ongoing Securities Fraud Investigation – Contact BFA Law
NEW YORK, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its…
2 weeks ago prnewswire.com
Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.
State-of-the-art facility planned to reinforce Medline's supply chain resilience in Michigan NORTHFIELD, Ill., Oct. 15, 2026 /PRNewswire/ -- Medline (Nasdaq: MDLN), the largest provider of…
2 weeks ago prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN
NEW YORK, Oct. 15, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN). Such investors are advised to contact…
2 weeks ago globenewswire.com
$MDLN Investors: A Securities Fraud Investigation is Pending on behalf of Medline Investors that Lost Money after 13% Stock Drop – Contact BFA Law
NEW YORK, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its…
2 weeks ago newsfilecorp.com
Medline Inc. Investigation Continues: Investors May Contact Kirby McInerney LLP, a Securities Fraud Law Firm, If You Lost Money On Your MDLN Investments
New York, New York--(Newsfile Corp. - October 13, 2026) - The law firm of Kirby McInerney LLP continues its investigation on behalf of Medline Inc. ("Medline" or the "Company") (NASDAQ: MDLN)…
2 weeks ago globenewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN
NEW YORK, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Medline Inc. (“Medline” or the “Company”) (NASDAQ: MDLN). Such investors are advised to…
2 weeks ago prnewswire.com
MDLN Stock Alert: Medline Product Quality Issues and Subsequent 13% Stock Drop Trigger Securities Fraud Investigation for Investors
BFA Law is investigating whether Medline Inc. committed securities fraud relating to statements about Medline's manufacturing and product quality. NEW YORK, Oct. 13, 2026 /PRNewswire/ -- Leading…
2 weeks ago prnewswire.com
Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care
Combines real-time inventory tracking with PointClickCare® integration to reduce manual work and improve supply visibility NORTHFIELD, Ill., Oct. 12, 2026 /PRNewswire/ -- Medline (Nasdaq: MDLN) today…
3 weeks ago defenseworld.net
Critical Survey: Medline (NASDAQ:MDLN) & NovoCure (NASDAQ:NVCR)
NovoCure (NASDAQ: NVCR - Get Free Report) and Medline (NASDAQ: MDLN - Get Free Report) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the…
-
3 weeks ago benzinga.com
Barclays Maintains Overweight on Medline, Lowers Price Target to $43
Barclays analyst Glen Santangelo maintains Medline (NASDAQ:MDLN) with a Overweight and lowers the price target from $45 to $43.
-
1 month ago benzinga.com
UBS Maintains Buy on Medline, Lowers Price Target to $43
UBS analyst Kevin Caliendo maintains Medline (NASDAQ:MDLN) with a Buy and lowers the price target from $45 to $43.
2 months ago benzinga.com
Medline Convenience Kits Impacted By Contamination In Recalled Becton Dickinson Products
FDA alerts providers as Medline corrects convenience kits with recalled BD applicators due to sterility and contamination risks.
-
2 months ago benzinga.com
JP Morgan Maintains Overweight on Medline, Lowers Price Target to $46
JP Morgan analyst Lisa Gill maintains Medline (NASDAQ:MDLN) with a Overweight and lowers the price target from $53 to $46.
-
2 months ago benzinga.com
Wells Fargo Maintains Equal-Weight on Medline, Lowers Price Target to $34
Wells Fargo analyst Stephen Baxter maintains Medline (NASDAQ:MDLN) with a Equal-Weight and lowers the price target from $45 to $34.
-
2 months ago benzinga.com
TD Cowen Maintains Buy on Medline, Lowers Price Target to $45
TD Cowen analyst Charles Rhyee maintains Medline (NASDAQ:MDLN) with a Buy and lowers the price target from $53 to $45.
-
2 months ago benzinga.com
RBC Capital Maintains Outperform on Medline, Lowers Price Target to $46
RBC Capital analyst Ryan Halsted maintains Medline (NASDAQ:MDLN) with a Outperform and lowers the price target from $53 to $46.
-
2 months ago benzinga.com
Truist Securities Maintains Buy on Medline, Lowers Price Target to $47
Truist Securities analyst Jailendra Singh maintains Medline (NASDAQ:MDLN) with a Buy and lowers the price target from $56 to $47.
-
2 months ago benzinga.com
Evercore ISI Group Maintains Outperform on Medline, Lowers Price Target to $39
Evercore ISI Group analyst Elizabeth Anderson maintains Medline (NASDAQ:MDLN) with a Outperform and lowers the price target from $48 to $39.
2 months ago benzinga.com
Gold Jumps 4%, Dow Jones Smashes Record Highs: Stock Market Today
Gold posts its biggest one-day gain since February and the Dow sets a record as Iran deal hopes cool inflation fears.
-
2 months ago benzinga.com
Medline Q2 Adj. EPS $0.50 Beats $0.32 Estimate, Sales $7.685B Beat $7.512B Estimate
Medline (NASDAQ:MDLN) reported quarterly earnings of $0.50 per share which beat the analyst consensus estimate of $0.32 by 56.25 percent. The company reported quarterly sales of $7.685 billion which…
-
3 months ago benzinga.com
Medline Strikes New Prime Vendor Agreement To Offer Access To Its Portfolio Of Medical-Surgical Products For Its Hospital, Physician Office Sites To Allina Health
Medline (NASDAQ:MDLN) today announced that it signed a new Prime Vendor agreement with Allina Health, a healthcare system based in Minneapolis that provides care to communities across Minnesota and…
4 months ago benzinga.com
Jim Cramer: 'Go For' AST SpaceMobile, Power Plant Maker 'Too Speculative'
Jim Cramer says Medline is "probably" the best IPO of 2026 and expects AST SpaceMobile to be profitable in two years.
4 months ago benzinga.com
Medline Distribution Center Fire Creates Near-Term Headwind: Analyst
Medline (MDLN) faces near-term headwinds after a major CA warehouse fire. William Blair analysts break down the impact.
-
5 months ago benzinga.com
Baird Maintains Outperform on Medline, Lowers Price Target to $45
Baird analyst Eric Coldwell maintains Medline (NASDAQ:MDLN) with a Outperform and lowers the price target from $57 to $45.
-
5 months ago benzinga.com
FDA Sends Warning Letter To Medline Over CGMP Violations For Finished Pharmaceuticals On May 28
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/medline-inc-724347-05282026
-
5 months ago benzinga.com
Barclays Maintains Overweight on Medline, Lowers Price Target to $45
Barclays analyst Glen Santangelo maintains Medline (NASDAQ:MDLN) with a Overweight and lowers the price target from $50 to $45.
-
5 months ago benzinga.com
Medline Announces That Medline Canada Has Signed Its First Prime Vendor Agreement In The Country And Is The First Medline Prime Vendor Relationship Outside The United States
Medline (NASDAQ:MDLN) announced that Medline Canada has signed its first Prime Vendor agreement in the country and is the first Medline Prime Vendor relationship outside the United States. The…
-
5 months ago benzinga.com
Medline Signs Prime Vendor Agreement With Rural Medical Services; Agreement Enables Access To Medline's Medical-Surgical Products And Supply Chain Solution Offerings
Medline (NASDAQ:MDLN) today announced that it signed a new Prime Vendor agreement with Rural Medical Services Inc., a community-based, non-profit federally qualified health center (FQHC) based in…
-
5 months ago benzinga.com
Medline Announces Secondary Public Offering Of 60M Shares
Medline Inc. (NASDAQ:MDLN) ("Medline") announced today that certain selling stockholders affiliated with Blackstone Inc., Hellman & Friedman LLC and a wholly owned subsidiary of the Abu Dhabi…
-
5 months ago benzinga.com
BNP Paribas Maintains Neutral on Medline, Lowers Price Target to $40
BNP Paribas analyst Navann Ty maintains Medline (NASDAQ:MDLN) with a Neutral and lowers the price target from $49 to $40.
-
5 months ago benzinga.com
Tigress Financial Maintains Buy on Medline, Raises Price Target to $62
Tigress Financial analyst Ivan Feinseth maintains Medline (NASDAQ:MDLN) with a Buy and raises the price target from $60 to $62.
-
5 months ago benzinga.com
Citigroup Maintains Buy on Medline, Lowers Price Target to $55
Citigroup analyst Patrick Donnelly maintains Medline (NASDAQ:MDLN) with a Buy and lowers the price target from $60 to $55.
-
5 months ago benzinga.com
Bernstein Maintains Outperform on Medline, Lowers Price Target to $54
Bernstein analyst Lee Hambright maintains Medline (NASDAQ:MDLN) with a Outperform and lowers the price target from $56 to $54.
-
5 months ago benzinga.com
FDA Announces Medline Recalls All Of Its Stock Keeping Units In Medline Branded Neuro Sponge Category With No Definite Market Re-Entry Date
https://www.fda.gov/medical-devices/letters-health-care-providers/disruptions-availability-neurosurgical-patties-sponges-and-strips-letter-health-care-providers
5 months ago benzinga.com
Medline Q1 2026 Earnings Call: Complete Transcript
Medline Q1 2026 Earnings Call: Complete Transcript
-
5 months ago benzinga.com
Medline Q1 EPS $0.33 Beats $0.23 Estimate, Sales $7.400B Beat $7.163B Estimate
Medline (NASDAQ:MDLN) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of $0.23 by 43.48 percent. The company reported quarterly sales of $7.400 billion which…